News from irras A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 29, 2020, 04:13 ET IRRAS Announces Release of Clinical Data that Validates Safety and Effectiveness of IRRAflow System in Treating Chronic Subdural Hematomas

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...


Aug 25, 2020, 04:13 ET IRRAS Granted Sixth Patent for Hummingbird ICP Monitoring Product Line from United States Patent and Trademark Office (USPTO)

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...


Aug 20, 2020, 02:10 ET IRRAS: Q2 Report 2020 - invitation to conference call and audiocast

On Thursday August 27, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q2 2020 interim report (which will have been ...


Aug 11, 2020, 04:15 ET IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...


Aug 05, 2020, 02:16 ET IRRAS to Present Virtually at Upcoming Investor Conferences

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company...


Jul 22, 2020, 03:57 ET IRRAS Announces Extension of CE Mark for IRRAflow System Until May 2024

IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...


Jun 30, 2020, 04:14 ET COVID-19 Delays Short Term Revenue, While the Commercial Launch of IRRAflow and Hummingbird Progresses

IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today provided...


Jun 15, 2020, 02:49 ET IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the promotion of...


May 19, 2020, 11:17 ET IRRAS has Been Approved for Listing on Nasdaq Stockholm and Publishes Prospectus

IRRAS AB (publ) ("IRRAS", or the "Company") announces that Nasdaq Stockholm's listing committee has approved the Company for listing on Nasdaq...


May 11, 2020, 02:27 ET IRRAS: Q1 Report 2020 - Invitation to Conference Call and Audiocast

On Thursday May 14, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q1 2020 interim report (which will have been...


May 07, 2020, 11:45 ET IRRAS to List on Nasdaq Stockholm

Nasdaq Stockholm's listing committee has decided that IRRAS AB (publ) ("IRRAS" or the "Company") fulfills the requirements for admission to trading...


Mar 25, 2020, 03:17 ET University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow

IRRAS, a global medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced a long-term...


Mar 20, 2020, 11:41 ET IRRAS Publishes Annual Report for 2019

IRRAS's annual report 2019 has today been published on the company's website. The report is available on:...


Feb 14, 2020, 02:37 ET IRRAS AB Publishes Interim Report for the Period January to December 2019

"The fourth quarter of 2019 was an important period of progress for IRRAS. We accomplished the remaining corporate milestones for the year,...


Jan 30, 2020, 03:04 ET IRRAS: Q4 Report 2019 - Invitation to Conference Call and Audiocast

IRRAS will host a conference call and an online presentation of its Q4 2019 interim report (which will have been published earlier on the 14th at...


Jan 07, 2020, 02:50 ET IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020

IRRAS, a global healthcare company with a comprehensive portfolio of innovative solutions for neurocritical care, today provides an update on the...


Dec 19, 2019, 18:30 ET IRRAS Receives Renewed CE Mark for the IRRAflow Catheter

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received CE...


Dec 19, 2019, 15:50 ET IRRAS Receives Renewed CE Mark for the IRRAflow Catheter

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received CE...


Dec 16, 2019, 02:19 ET IRRAS Announces US Launch of Hummingbird Products for Neurocritical Care

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the launch of its...


Dec 09, 2019, 02:15 ET IRRAflow® Wins CONNECT's "2019 Most Innovative New Product" Award

IRRAS AB (NASDAQ Stockholm: IRRAS), a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care,...


Nov 21, 2019, 15:31 ET IRRAS Announces FDA Clearance of New 510(K) Filing to Expand the Time of Use of IRRAflow®

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that the US FDA has...


Nov 14, 2019, 02:18 ET IRRAS AB publishes Interim Report for the Period January to September 2019

"Since the US is the world's largest market for neurosurgical procedures, we have focused much of our team's resources toward supporting a successful ...


Nov 11, 2019, 02:09 ET IRRAS Announces Addition of Dr. Coenraad Tamse as Vice President, International Sales

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the hiring of Dr....


Oct 31, 2019, 03:10 ET IRRAS - Q3 Report 2019 - Invitation to Conference Call and Audiocast

On Thursday November 14, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q3 2019 interim report (which will...


Oct 18, 2019, 17:58 ET IRRAS Announces Participation at the 69th Congress of Neurological Surgeons' Annual Meeting (CNS 2019)

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it will be...